Wang et al (22) demonstrated that in colon cancer cells, activated PXR was able to induce fibroblast growth factor 19 (FGF19)-dependent cancer cell proliferation and inhibit cell apoptosis. Here, NR1I2 is linked to malignant colon neoplasm.